OOIR: Observatory of International Research

Papers

(The TQCC of Addiction Science & Clinical Practice is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou	67
Advancing pre-exposure prophylaxis (PrEP) implementation for people who use drugs: an introduction to and lessons from the special series	54
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals	48
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series	35
Patient perceptions of the use of e-cigarettes in smoking treatment programs: a qualitative analysis	32
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use	31
The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with	28
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)	24
“Cigarettes led me back to smoking tik”: lived experience perspectives on tobacco use during substance use treatment and recovery in South Africa	23
Effects of different exercise types on craving in substance use disorder patients with drug dependence -network meta-analysis and dose-response relationships based on frequentist and Bayesian models	22
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda	20
Implementation process evaluation and preliminary effect analysis of an outpatient multidisciplinary follow-up program for adolescents with acute alcohol intoxication in Belgium: the SPIRIT pilot stud	19
Virtual reality interventions in the assessment and treatment of alcohol use disorder - a systematic scoping review on methodology	19
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study	19
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study	17
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access	17
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process	16
Virtual reality cue exposure as an add-on to smoking cessation group therapy: a randomized controlled trial	16
Implementation outcomes and strategies of a peer recovery coach program: findings from a qualitative assessment in the U.S. South, 2024–2025	16
Cost of implementing evidence-based practices to reduce opioid overdose fatalities in New York State communities	15
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study	15
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use	15
Trial experiences with dyadic breathalyzer technology for alcohol monitoring and feedback among couples living with HIV in South Africa	14
Patient evaluation of a smartphone application for telehealth care of opioid use disorder	14
Correction: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population	14

Study protocol for a randomized trial examining a peer grief support approach for people grieving drug overdose deaths	14
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial	14
Distilling the evidence for GLP-1 receptor agonists in alcohol use disorder	14
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State	13
Spatial accessibility of substance use disorder treatment programs, compared with other health care facilities, in New York State, 2024	13
Adapting the Grog survey app for alcohol screening and feedback in aboriginal and Torres Strait Islander health services: a mixed methods study protocol	13
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder	13
“Take services to the people”: strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda	12
Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods	12
Correction: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis	12
What smartphone apps exist to support recovery from opioid use disorder? A content analysis of publicly available opioid-related smartphone apps	12
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with metham	12
Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study	12
Implementation of low-dose buprenorphine induction at a syringe services program	11
Proceedings of the 18th Annual Conference of INEBRIA	11
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical	11
“There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits	11
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation	11
An investigation of fentanyl and methamphetamine use among first-time arrestees from 25 county jails across the U.S. in 2023	10
Substance use disorder bridge clinics: models, evidence, and future directions	10
Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics	10
“It beats the hell out of going to a hospital”: service user experiences of telemedicine-based symptom-triggered alcohol withdrawal management	10
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis	10
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches	10
Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program	10
Iatrogenic physiologic opioid dependence masquerading as recurrent acute pancreatitis flares: case series	10
A stakeholder-driven approach to designing a peer recovery coach role for implementation in community-oriented primary care teams in South Africa	9
Patient characteristics associated with their level of twelve-step attendance prior to entry into treatment for substance use disorders	9
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder	9
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis	9
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study	9
A protocol for a randomized comparison of extended-release versus sublingual buprenorphine among pre-trial detainees in jail	9
24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review	9
Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries	9
The development and initial validation of the Russian version of the BASIS-24	9
A systematic review of substance use screening in outpatient behavioral health settings	9
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants	9
Patient experiences of buprenorphine dispensing from a mobile medical unit	9
Chronic unilateral groin pain in a young patient who injects drugs: a case report of needle fragment retentions	9
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods	8
Comparison of heroin and fentanyl use in US nationally representative surveys	8
A mixed methods analysis of clinics’ perspectives on community factors influencing access to medications for opioid use disorder	8
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey	8
Factors associated with alcohol screening and brief interventions: a cross-sectional study of cardiology clinicians in Sweden	8
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol	8
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder	8
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d	8
Rethinking trazodone for insomnia in alcohol use disorder	8
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care	7
Expedited referrals from community health center to opioid treatment program: innovative approaches to improving access to methadone treatment for patients who use opioids and experience homelessness	7

Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky	7
Using a quality improvement framework to evaluate the feasibility of implementing a patient-reported outcome measure for recovery in an office-based treatment setting for opioid use disorder	7
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial	7
Rural providers’ attitudes toward integrating harm reduction strategies and PrEP prescribing into rural primary care settings in the US. Southeast and Midwest	7
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	7
Understanding overdose risk and response in permanent supportive housing: results of focus groups with tenants, staff, and leaders	7
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	7
Subtypes and service utilization among opioid use disorder patients at a community health center: findings from a medically underserved urban area of the Northeastern United States	7
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology	6
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 rec	6
Proceedings of the 17th Annual International INEBRIA Conference	6
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services	6
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versu	6
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design	6
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	6
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single	6
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool—a protocol paper	6
Attitudes and training related to substance use in pediatric emergency departments	6
“We need all hands on deck”: characterizing addiction medicine training in Canada—a mixed methods study of fellowship program directors	6